Effect of zinc sulphate in papilloma virus
Phase 1
Recruiting
- Conditions
- Abnormal papsmear and cervical cytology.
- Registration Number
- IRCT20210407050882N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
positive HPV DNA test
LSIL in pap smear
Ascus in pap smear
Exclusion Criteria
Pregnancy
Breast feeding
Immunocompromised state deasie
Perior history of cervical cone biopsy or LEEP
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effect of oral zinc sulphat(in department variable)in clearance of cervical human papilloma virus (dependent variable). Timepoint: Both groups check their serum zinc levels at start and the end of study,which is before the star of zinc supplement and 30 days after the last dose of zinc for intervention group.Than in both groups do pap smear and cervical HPV typing. Method of measurement: Repeat pap smear and HPV typing in same laborator.
- Secondary Outcome Measures
Name Time Method